Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 6Active not recruiting 3Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma, Large B-Cell, Diffuse 18Sarcoma 15Burkitt Lymphoma 9Breast Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Follicular 7Lymphoma, B-Cell 7Ovarian Neoplasms 6Lymphoma 6Hodgkin Disease 6Endometrial Neoplasms 5Osteosarcoma 4Neuroblastoma 4Lymphoma, Non-Hodgkin 4Liposarcoma 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Peritoneal Neoplasms 3Neoplasms 3Leukemia, Biphenotypic, Acute 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Hemangiosarcoma 3Colorectal Neoplasms 3Uterine Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2

Interventions

Temozolomide 6Cyclophosphamide 5cabozantinib 4Vincristine 4fludarabine 3Radiotherapy 3Irinotecan 3liposomal doxorubicin 2irinotecan sucrosofate 2Zoledronic Acid 2Topotecan 2Specimen Handling 2PM 01183 2Ifosfamide 2Etoposide 2Eflornithine 2Drug Therapy 2Doxorubicin 2trilaciclib 1trifluridine tipiracil drug combination 1talazoparib 1silmitasertib 1romiplostim 1regorafenib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1naxitamab 1fluzoparib 1fludarabine phosphate 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Sarcoma, Ewing × Doxorubicin × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
15 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡